1α,25-dihydroxyvitamin D3 acts predominately in mature osteoblasts under conditions of high extracellular phosphate to increase fibroblast growth factor 23 production in vitro

Journal of Endocrinology

Volumn 206, Issue 3, 2010, Pages 279-286

  Yamamoto, Ryoko ^a   Minamizaki, Tomoko ^a   Yoshiko, Yuji ^a   Yoshioka, Hirotaka ^a   Tanne, Kazuo ^a   Aubin, Jane E ^b   Maeda, Norihiko ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 23; FOSCARNET; HYPOCALCIN; MESSENGER RNA; PARATHYROID HORMONE; PHOSPHATE; PROSTAGLANDIN E2; CALCITRIOL; CALCITRIOL RECEPTOR; FIBROBLAST GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IN VITRO STUDY; NONHUMAN; OSTEOBLAST; OSTEOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; ANALYSIS OF VARIANCE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG EFFECT; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANALYSIS OF VARIANCE; ANIMALS; CALCITRIOL; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLAST GROWTH FACTORS; OSTEOBLASTS; PARATHYROID HORMONE; PHOSPHATES; RATS; RECEPTORS, CALCITRIOL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77955625789     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-10-0058     Document Type: Article

References (54)

1. 3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism. Journal of Steroid Biochemistry and Molecular Biology 103 381-388.
2. Beck GR Jr 2003 Inorganic phosphate as a signaling molecule in osteoblast differentiation. Journal of Cellular Biochemistry 90 234-243. (Pubitemid 37222192)
3. Bellows CG, Aubin JE, Heersche JN & Antosz ME 1986 Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcified Tissue International 38 143-154.
4. Bellows CG, Heersche JN & Aubin JE 1992 Inorganic phosphate added exogenously or released from β-glycerophosphate initiates mineralization of osteoid nodules in vitro. Bone and Mineral 17 15-29.
5. Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-o M, Mohammadi M, Sirkis R, Naveh-Many T & Silver J 2007 The parathyroid is a target organ for FGF23 in rats. Journal of Clinical Investigation 117 4003-4008. (Pubitemid 350224109)
6. Burnett-Bowie SA, Henao MP, Dere ME, Lee H & Leder BZ 2009 Effects of hPTH(1-34) infusion on circulating serum phosphate, 1,25-dihydroxyvitamin D and FGF23 levels in healthy men. Journal of Bone and Mineral Research 24 1681-1685.
7. Erben RG, Mayer D, Weber K, Jonsson K, Jüppner H & Lanske B 2005 Overexpression of human PHEX under the human β-actin promoter does not fully rescue the Hyp mouse phenotype. Journal of Bone and Mineral Research 20 1149-1160. (Pubitemid 40863802)
8. Feng JQ, Ward LM, Liu S, Lu Y, Xie Y, Yuan B, Yu X, Rauch F, Davis SI, Zhang S et al. 2006 Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nature Genetics 38 1310-1315. (Pubitemid 44646294)
9. 3: implications in cell growth and differentiation. Endocrine Reviews 23 763-786.
10. Hatch NE, Nociti F, Swanson E, Bothwell M & Somerman M 2005 FGF2 alters expression of the pyrophosphate/phosphate regulating proteins, PC-1, ANK and TNAP, in the calvarial osteoblastic cell line, MC3T3E1(C4). Connective Tissue Research 46 184-192.
11. 14C]phosphonoformic acid as a useful probe to determine the density and its change in response to parathyroid hormone. Journal of Biological Chemistry 266 11528-11536.
12. Ito M, Sakai Y, Furumoto M, Segawa H, Haito S, Yamanaka S, Nakamura R, Kuwahata M & Miyamoto K 2005 Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells. American Journal of Physiology. Endocrinology and Metabolism 288 E1101-E1109. (Pubitemid 40726796)
13. Kalajzic I, Braut A, Guo D, Jiang X, Kronenberg MS, Mina M, Harris MA, Harris SE & Rowe DW 2004 Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene. Bone 35 74-82. (Pubitemid 38789150)
14. Kawaguchi H, Manabe N, Miyaura C, Chikuda H, Nakamura K & Kuro-o M 1999 Independent impairment of osteoblast and osteoclast differentiation in klotho mouse exhibiting low-turnover osteopenia. Journal of Clinical Investigation 104 229-237.
15. Kawata T, Imanishi Y, Kobayashi K, Miki T, Arnold A, Inaba M & Nishizawa Y 2007 Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism. Journal of the American Society of Nephrology 18 2683-2688. (Pubitemid 47531195)
16. 3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. American Journal of Physiology. Gastrointestinal and Liver Physiology 289 G1036-G1042.
17. Kurosu H, Choi M, Ogawa Y, Dickson AS, Goetz R, Eliseenkova AV, Mohammadi M, Rosenblatt KP, Kliewer SA & Kuro-o M 2007 Tissue-specific expression of βKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. Journal of Biological Chemistry 282 26687-26695. (Pubitemid 47501965)
18. Larsson T, Marsell R, Schipani E, Ohlsson C, Ljunggren O, Tenenhouse HS, Juppner H & Jonsson KB 2004 Transgenic mice expressing fibroblast growth factor 23 under the control of the α1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology 145 3087-3094. (Pubitemid 38829975)
19. Liu S & Quarles LD 2007 How fibroblast growth factor 23 works. Journal of the American Society of Nephrology 18 1637-1647. (Pubitemid 46870300)
20. Liu S, Tang W, Zhou J, Stubbs JR, Luo Q, Pi M & Quarles LD 2006a Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. Journal of the American Society of Nephrology 17 1305-1315. (Pubitemid 43673410)
21. Liu S, Zhou J, Tang W, Jiang X, Rowe DW & Quarles LD 2006b Pathogenic role of Fgf23 in Hyp mice. American Journal of Physiology. Endocrinology and Metabolism 291 E38-E49. (Pubitemid 44035308)
22. Liu S, Zhou J, Tang W, Menard R, Feng JQ & Quarles LD 2008 Pathogenic role of Fgf23 in Dmp1-null mice. American Journal of Physiology. Endocrinology and Metabolism 295 E254-E261.
23. Liu S, Tang W, Fang J, Ren J, Li H, Xiao Z & Quarles LD 2009 Novel regulators of Fgf23 expression and mineralization in Hyp bone. Molecular Endocrinology 23 1505-1518.
24. Mirams M, Robinson BG, Mason RS & Nelson AE 2004 Bone as a source of FGF23: regulation by phosphate? Bone 35 1192-1199.
25. Murer H, Lötsher M, Kaissling B, Levi M, Kempson SA & Biber J 1996 Renal brush border membrane Na/Pi-cotransport: molecular aspects in PTH-dependent and dietary regulation. Kidney International 49 1769-1773. (Pubitemid 126440215)
26. 3 production in murine renal tubules. Biochemical and Biophysical Research Communications 381 283-287.
27. Narumiya S & FitzGerald GA 2001 Genetic and pharmacological analysis of prostanoid receptor function. Journal of Clinical Investigation 108 25-30. (Pubitemid 32634917)
28. Ohnishi M, Nakatani T, Lanske B & Razzaque MS 2009 Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1α-hydroxylase. Kidney International 75 1166-1172.
29. Qin C, D'Souza R & Feng JQ 2007 Dentin matrix protein 1 (DMP1): new and important roles for biomineralization and phosphate homeostasis. Journal of Dental Research 86 1134-1141.
30. Quarles LD 2003 FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. American Journal of Physiology. Endocrinology and Metabolism 285 E1-E9.
31. Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespack S, Gupta A, Hannon T, Econs MJ et al. 2003 FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. Journal of Clinical Investigation 112 683-692. (Pubitemid 38057709)
32. 3 and phosphorus in vivo. Journal of Biological Chemistry 280 2543-2549.
33. Samadfam R, Richard C, Nguyen-Yamamoto L, Bolivar I & Goltzman D 2009 Bone formation regulates circulating concentrations of fibroblast growth factor 23. Endocrinology 150 4835-4845.
34. Selz T, Caverzasio J & Bonjour JP 1989 Regulation of Na-dependent Pi transport by parathyroid hormone in osteoblast-like cells. American Journal of Physiology 256 E93-E100.
35. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S & Yamashita T 2004 FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. Journal of Bone and Mineral Research 19 429-435. (Pubitemid 38787398)
36. Sitara D, Razzaque MS, St-Arnaud R, Huang W, Taguchi T, Erben RG & Lanske B 2006 Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals. American Journal of Physiology 169 2161-2170. (Pubitemid 351181975)
37. Suzawa T, Miyaura C, Inada M, Maruyama T, Sugimoto Y, Ushikubi F, Ichikawa A, Narumiya S & Suda T 2000 The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology 141 1554-1559. (Pubitemid 32269125)
38. Suzuki A, Ghayor C, Guicheux J, Magne D, Quillard S, Kakita A, Ono Y, Miura Y, Oiso Y, Itoh M et al. 2006 Enhanced expression of the inorganic phosphate transporter Pit-1 is involved in BMP-2-induced matrix mineralization in osteoblast-like cells. Journal of Bone and Mineral Research 21 674-683.
39. Suzuki A, Ammann P, Nishiwaki-Yasuda K, Sekiguchi S, Asano S, Nagao S, Kaneko R, Hirabayashi M, Oiso Y, Itoh M et al. 2010 Effects of transgenic Pit-1 overexpression on calcium phosphate and bone metabolism. Journal of Bone and Mineral Metabolism 28 139-148.
40. Takeshita K, Fujimori T, Kurotaki Y, Honjo H, Tsujikawa H, Yasui K, Lee JK, Kamiya K, Kitaichi K, Yamamoto K et al. 2004 Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression. Circulation 109 1176-1182.
41. Tat SK, Pelletier JP, Lajeunesse D, Fahmi H, Duval N & Martel-Pelletier J 2008 Differential modulation of RANKL isoforms by human osteoarthritic subchondral bone osteoblasts: influence of osteotropic factors. Bone 43 284-291.
42. The ADHR Consortium 2000 Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nature Genetics 26 345-348.
43. Toyosawa S, Shintani S, Fujiwara T, Ooshima T, Sato A, Ijuhin N & Komori T 2001 Dentin matrix protein 1 is predominantly expressed in chicken and rat osteocytes but not in osteoblasts. Journal of Bone and Mineral Research 16 2017-2026. (Pubitemid 32995392)
44. Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S & Yamashita T 2006 Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444 770-774. (Pubitemid 44949607)
45. Veldman CM, Schlapfer I & Schmid C 1998 Prostaglandin E2 stimulates sodium-dependent phosphate transport in osteoblastic cells via a protein kinase C-mediated pathway. Endocrinology 139 89-94. (Pubitemid 28166295)
46. Wang H, Yoshiko Y, Yamamoto R, Minamizaki T, Kozai K, Tanne K, Aubin JE & Maeda N 2008 Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. Journal of Bone and Mineral Research 23 939-948. (Pubitemid 351768812)
47. Wortsman J, Haddad JD, Posillico JT & Brown EM 1986 Primary hyperparathyroidism with low serum 1,25-dihydroxyvitamin D levels. Journal of Clinical Endocrinology and Metabolism 62 1305-1308. (Pubitemid 16085297)
48. Wu S, Yoshiko Y & De Luca F 2006 Stanniocalcin 1 acts as a paracrine regulator of growth plate chondrogenesis. Journal of Biological Chemistry 281 5120-5127. (Pubitemid 43847777)
49. Yoshida T, Fujimori T & Nabeshima Y 2002 Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1α-hydroxylase gene. Endocrinology 143 683-689. (Pubitemid 34107224)
50. Yoshiko Y, Maeda N & Aubin JE 2003 Stanniocalcin 1 stimulates osteoblast differentiation in rat calvaria cell cultures. Endocrinology 144 4134-4143. (Pubitemid 37088769)
51. Yoshiko Y, Candeliere GA, Maeda N & Aubin JE 2007a Osteoblast autonomous Pi regulation via Pit1 plays a role in bone mineralization. Molecular and Cellular Biology 27 4465-4474. (Pubitemid 46906569)
52. Yoshiko Y, Wang H, Minamizaki T, Ijuin C, Yamamoto R, Suemune S, Kozai K, Tanne K, Aubin JE & Maeda N 2007b Mineralized tissue cells are a principal source of FGF23. Bone 40 1565-1573. (Pubitemid 46756409)
53. Yu X & White KE 2005 FGF23 and disorders of phosphate homeostasis. Cytokine and Growth Factor Reviews 16 221-232.
54. Yu X, Sabbagh Y, Davis SI, Demay MB & White KE 2005 Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations. Bone 36 971-977. (Pubitemid 40797997)